glp-1 therapy meal timing weight loss studies Part 1: Setting Realistic Expectations – Sarah Hormachea GLP-1 Weight Loss Drugs: Miracle,

Diabetes Care 2006;29:60712

Ethics declarations Conflict of interest The authors declare no competing interests

Areas like the abdomen, thigh, or upper arm have enough subcutaneous tissue to deliver a steady drip of medication into your bloodstream

Cardiovascular effects of currently used gliptins Sitagliptin The effects of this medicationa beta-amino acidon cardiovascular outcomes in patients with T2DM have been recently reported by Green et al

However, additional concerns have been noted, including modest increases in heart rate observed in clinical trials and reports of dysesthesia, where normal sensations are perceived as painful, in some users